Endo Makes an Acquisition

Endo Health Solutions (NASDAQ: ENDP  ) is attempting to grow through asset purchases. The company announced that Qualitest, a subsidiary, has agreed to acquire Boca Pharmaceutical for $225 million in cash.

Boca is a privately held firm headquartered in Florida that concentrates on the manufacture of specialty generic drugs. Endo said it expects the deal to be "immediately accretive" to its 2013 adjusted diluted earnings per share. As a stand-alone entity, Boca's forecast EBITDA for full-year 2013 is anticipated to come in at roughly $50 million.

Endo said the acquisition would be funded by its cash on hand.

The purchase is not planned to be an isolated incident. In the press release announcing the news, Endo quoted CEO Rajiv De Silva as saying that it "is the first of several transactions we plan to execute as we transform Endo into a more focused specialty health care company with a lean operating model, able to deliver consistent earnings and revenue growth for our shareholders."

The Boca deal is expected to close before the end of this year.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2614405, ~/Articles/ArticleHandler.aspx, 10/25/2014 11:25:14 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement